Together, our findings suggest that ERbeta can promote NSCLC cell invasion via altering the ERbeta/circ-TMX4/miR-622/CXCR4 signaling, and targeting this newly circ-TMX4/miR-622/CXCR4 signaling may help us find new treatment strategies to better suppress NSCLC progression.
Estrogen receptor beta promotes lung cancer invasion via increasing CXCR4 expression.